Ultrasonographic assessment of brain injury in preterm infants
Ultrasonographic Prognostic Scale of Periventricular Hemorrhagic Infarction in Preterm Infants With Gestational Age <30 Weeks
This study is testing a new ultrasound method to check brain health in preterm infants under 30 weeks old to see how it affects their development by age two.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 360 (estimated) |
| Sex | All |
| Sponsor | Hospital General Universitario Gregorio Marañon Academic / other |
| Locations | 1 site (Madrid) |
| Trial ID | NCT05918016 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on preterm infants born with a gestational age of less than 30 weeks at the Neonatal Care Unit of Gregorio Marañon Hospital in Madrid, Spain. It employs a new ultrasonographic prognostic scale to evaluate periventricular hemorrhagic infarction and its impact on neurodevelopmental outcomes by the age of two years. The study involves routine cranial ultrasounds to monitor brain health and development in these vulnerable infants.
Who should consider this trial
Good fit: Ideal candidates for this study are preterm infants born before 30 weeks of gestation without any significant brain malformations or genetic disorders.
Not a fit: Patients with brain malformations, genetic syndromes, metabolic disorders, or chromosomal abnormalities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve early detection and management of brain injuries in preterm infants, potentially enhancing their long-term neurodevelopmental outcomes.
How similar studies have performed: While this specific approach is novel, similar studies using ultrasonography for assessing brain injuries in preterm infants have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gestacional Age \< 30 weeks Exclusion Criteria: * Brain malformation * Genetic syndrome * Metabolic disorders * Chromosomal abnormality * None cranial ultrasound
Where this trial is running
Madrid
- Gregorio Marañon Hospital — Madrid, Spain (Recruiting)
Study contacts
- Study coordinator: Manuel Sánchez Luna, Doctor
- Email: msluna@salud.madrid.org
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.